Top Markets
Coin of the day
Synovics Pharmaceuticals, Inc. Synovics Pharmaceuticals, Inc.

Synovics Pharmaceuticals, Inc.

SYVC
Rangering i aksjer #42246
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the... Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$2.98K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Synovics Pharmaceuticals, Inc. (SYVC)

Kategori

Inntekter for Synovics Pharmaceuticals, Inc. (SYVC)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Synovics Pharmaceuticals, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Synovics Pharmaceuticals, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$12.62B -
US
$6.02B -
NL
- -
CH
$10.11B -
BE
- -
KR